home / stock / vynt / vynt news

VYNT News and Press, Vyant Bio Inc. From 11/15/22

Stock Information
Company Name: Vyant Bio Inc.
Stock Symbol: VYNT
Market: NASDAQ
Website: vyantbio.com
Menu
VYNT VYNT Quote VYNT Short VYNT News VYNT Articles VYNT Message Board
Get VYNT Alerts

News, Short Squeeze, Breakout and More Instantly...
VYNT - Vyant Bio GAAP EPS of -$0.62 beats by $0.08, revenue of $0.15M

Vyant Bio press release ( NASDAQ: VYNT ): Q3 GAAP EPS of -$0.62 beats by $0.08 . Revenue of $0.15M (-42.3% Y/Y). Shares -2.63% PM. For further details see: Vyant Bio GAAP EPS of -$0.62 beats by $0.08, revenue of $0.15M

VYNT - Vyant Bio Reports Third Quarter 2022 Results and Provides Strategic and Business Highlights

Q3 2022 and Recent Scientific and Business Highlights Completed the sale of its vivoP harm subsidiary to Reaction Biology Corporation for $5.5 million in an upfront cash payment Delivered platform and poster presentations at the 2022 CDKL5 Forum hosted by the Loulou ...

VYNT - Vyant Bio Presents Key Takeaways from Platform and Poster Presentations at the 2022 CDKL5 Forum Hosted by the Loulou Foundation

CHERRY HILL, N.J., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. The Company’...

VYNT - Vyant Bio to Participate at Neuroscience 2022, the 52nd Annual Gathering of the Society for Neuroscience, on November 12-16

CHERRY HILL, N.J., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. The Company’...
VYNT - Vyant Bio Teams Up with the International Rett Syndrome Foundation to Host Local Viewing Party in Honor of the 3rd Annual 'Raise a Glass for Rett Gala'

Charity Event to Drive Awareness and Support Rett Families Around the World CHERRY HILL, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company rei...

VYNT - Vyant Bio to sell unit vivoPharm to Reaction Biology for $5.5M

Vyant Bio ( NASDAQ: VYNT ) said Thursday it will sell its unit vivoPharm in Hershey, Pennsylvania to contract research organization Reaction Biology for $5.5M in cash. Shares of Vyant ( VYNT ) edged 4.6% higher on Thursday. Reaction will retain U.S. p...

VYNT - Reaction Biology and Vyant Bio Announce Closing of Definitive Agreement to Acquire U.S. Operations of Vyant Bio, Inc. Subsidiary

~ Reaction Biology Acquire s the Hershey, Pennsylvania-Based U.S. Operations of Vyant Bio Subsidiary vivoPharm PTY Ltd. ~ ~ Transaction E xpands Reaction Biology’s Capabilities to P rovide Customers with S olut...
VYNT - Vyant Bio down 1% on one-for-five reverse stock split

Vyant Bio ( NASDAQ: VYNT ) is trading 1% lower after the company will effect a 1-for-5 reverse stock split of its outstanding common stock. The company will become effective for trading purposes as of the commencement of trading on Wednesday, November 2. Vyant...

VYNT - Vyant Bio Announces One-for-Five Reverse Stock Split

CHERRY HILL, N.J., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. The Company’...

VYNT - Vyant Bio Announces Participation at the 2022 CDKL5 Forum Hosted by the Loulou Foundation on November 7-8, 2022

P latform and P oster Presentation s on Vyant Bio’s Human First Drug Discovery Platform and Progress on CDKL5 Deficiency Disorder (CDD) CHERRY HILL, N.J., Oct. 27, 2022 (GLOBE NEWSWI...
Previous 10 Next 10